|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 388 out of 388 for C5ar1

<< First    < Previous  |  Next >    Last >>
0.024s
Type Details Score
Publication
First Author: Magdaleno S
Year: 2006
Journal: PLoS Biol
Title: BGEM: an in situ hybridization database of gene expression in the embryonic and adult mouse nervous system.
Volume: 4
Issue: 4
Pages: e86
Publication
First Author: Carninci P
Year: 2005
Journal: Science
Title: The transcriptional landscape of the mammalian genome.
Volume: 309
Issue: 5740
Pages: 1559-63
Publication        
First Author: MGD Nomenclature Committee
Year: 1995
Title: Nomenclature Committee Use
Publication        
First Author: GemPharmatech
Year: 2020
Title: GemPharmatech Website.
Publication
First Author: Skarnes WC
Year: 2011
Journal: Nature
Title: A conditional knockout resource for the genome-wide study of mouse gene function.
Volume: 474
Issue: 7351
Pages: 337-42
Publication        
First Author: Cyagen Biosciences Inc.
Year: 2022
Title: Cyagen Biosciences Website.
Publication        
First Author: AgBase, BHF-UCL, Parkinson's UK-UCL, dictyBase, HGNC, Roslin Institute, FlyBase and UniProtKB curators
Year: 2011
Title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Publication        
First Author: UniProt-GOA
Year: 2012
Title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Publication        
First Author: GOA curators
Year: 2016
Title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Publication        
First Author: The Gene Ontology Consortium
Year: 2010
Title: Automated transfer of experimentally-verified manual GO annotation data to mouse-human orthologs
Publication
First Author: Diez-Roux G
Year: 2011
Journal: PLoS Biol
Title: A high-resolution anatomical atlas of the transcriptome in the mouse embryo.
Volume: 9
Issue: 1
Pages: e1000582
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2002
Title: Mouse Genome Informatics Computational Sequence to Gene Associations
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2010
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome U74 Array Platform (A, B, C v2).
Publication      
First Author: MGI Genome Annotation Group and UniGene Staff
Year: 2015
Journal: Database Download
Title: MGI-UniGene Interconnection Effort
Publication        
First Author: Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas
Year: 2010
Title: Annotation inferences using phylogenetic trees
Publication      
First Author: Mouse Genome Database and National Center for Biotechnology Information
Year: 2000
Journal: Database Release
Title: Entrez Gene Load
Publication      
First Author: Allen Institute for Brain Science
Year: 2004
Journal: Allen Institute
Title: Allen Brain Atlas: mouse riboprobes
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform
Publication      
First Author: Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI)
Year: 2010
Journal: Database Download
Title: Consensus CDS project
Publication      
First Author: Mouse Genome Informatics Group
Year: 2003
Journal: Database Procedure
Title: Automatic Encodes (AutoE) Reference
Publication      
First Author: Bairoch A
Year: 1999
Journal: Database Release
Title: SWISS-PROT Annotated protein sequence database
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations
Publication      
First Author: Mouse Genome Informatics
Year: 2010
Journal: Database Release
Title: Protein Ontology Association Load.
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and loading genome assembly coordinates from NCBI annotations
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform
Publication
First Author: Ng AN
Year: 2023
Journal: iScience
Title: Amyloid-β(1-42) oligomers enhance mGlu(5)R-dependent synaptic weakening via NMDAR activation and complement C5aR1 signaling.
Volume: 26
Issue: 12
Pages: 108412
Publication
First Author: Titiz M
Year: 2024
Journal: Nat Commun
Title: Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosis.
Volume: 15
Issue: 1
Pages: 10142
Allele
Name: complement component 5a receptor 1; endonuclease-mediated mutation 2, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Humanized sequence, Inserted expressed sequence
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Allele
Name: complement component 5a receptor 1; endonuclease-mediated mutation 3, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Allele
Name: complement component 5a receptor 1; targeted mutation 1, Shanghai Model Organisms Center
Allele Type: Targeted
Attribute String: Humanized sequence, Inserted expressed sequence
Allele
Name: complement component 5a receptor 2; targeted mutation 1, Shanghai Model Organisms Center
Allele Type: Targeted
Attribute String: Humanized sequence, Inserted expressed sequence
Allele
Name: complement component 5a receptor 1; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, No functional change
Strain
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
Allele
Name: complement component 5a receptor 1; targeted mutation 1.1, Charles R Mackay
Allele Type: Targeted
Attribute String: Humanized sequence, Inserted expressed sequence, Null/knockout
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Strain
Attribute String: coisogenic, mutant strain, targeted mutation
Protein Domain
Type: Family
Description: The activation of the complement cascade produces a number of small fragments that are bioactive: potent chemoattractants and secretagogues that act on immune and non-immune cells []. Similar peptides can also be released by the actions of non-complement proteases, for instance during clotting []. Initially these were termed anaphylatoxins because of their effect on mast cell histamine release, but were reclassified as complement component peptides. They include C3a and C5a, which are involved immune response [], neural development and organ regeneration [, ]. A third peptide, C4a, has a similar structure, but it is inactive in humans []. Since the primary function of complement component peptides is in inflammation, they are important targets for the development of anti-inflammatory therapies [].The anaphylatoxin chemotactic receptors (also known as complement peptide receptors) are a group of rhodopsin-like G-protein coupled receptors (GPCRs) [, , , ]. There are three subtypes: C3a anaphylatoxin chemotactic receptor (C3AR1) [], C5a anaphylatoxin chemotactic receptor (C5AR1) []and C5a anaphylatoxin chemotactic receptor C5L2 (C5AR2) []. Both C3AR1 and C5AR1 receptors are classical GPCRs. However, C5AR2 appears to be permanently uncoupled from G proteins but can associate with beta-arrestin []. Nevertheless, it has been shown that activation of both C5AR1 and C5AR2 is required for a full pro-inflammatory response, particularly in mice []. Several receptor antagonists have been reported [, , , ], although none, so far, have been show to be effective in humans. This entry represents C3a anaphylatoxin chemotactic receptors and C5a anaphylatoxin chemotactic receptor 1/2.
Protein Domain
Type: Family
Description: The activation of the complement cascade produces a number of small fragments that are bioactive: potent chemoattractants and secretagogues that act on immune and non-immune cells []. Similar peptides can also be released by the actions of non-complement proteases, for instance during clotting []. Initially these were termed anaphylatoxins because of their effect on mast cell histamine release, but were reclassified as complement component peptides. They include C3a and C5a, which are involved immune response [], neural development and organ regeneration [, ]. A third peptide, C4a, has a similar structure, but it is inactive in humans []. Since the primary function of complement component peptides is in inflammation, they are important targets for the development of anti-inflammatory therapies [].The anaphylatoxin chemotactic receptors (also known as complement peptide receptors) are a group of rhodopsin-like G-protein coupled receptors (GPCRs) [, , , ]. There are three subtypes: C3a anaphylatoxin chemotactic receptor (C3AR1) [], C5a anaphylatoxin chemotactic receptor (C5AR1) []and C5a anaphylatoxin chemotactic receptor C5L2 (C5AR2) []. Both C3AR1 and C5AR1 receptors are classical GPCRs. However, C5AR2 appears to be permanently uncoupled from G proteins but can associate with beta-arrestin []. Nevertheless, it has been shown that activation of both C5AR1 and C5AR2 is required for a full pro-inflammatory response, particularly in mice []. Several receptor antagonists have been reported [, , , ], although none, so far, have been show to be effective in humans. This entry represents C5AR2, also known as complement component 5a receptor 2.
Publication
First Author: Hartmann K
Year: 1997
Journal: Blood
Title: C3a and C5a stimulate chemotaxis of human mast cells.
Volume: 89
Issue: 8
Pages: 2863-70
Publication
First Author: Bellows-Peterson ML
Year: 2012
Journal: J Med Chem
Title: De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation.
Volume: 55
Issue: 9
Pages: 4159-68
Publication
First Author: Takafuji S
Year: 1994
Journal: Int Arch Allergy Immunol
Title: Degranulation from human eosinophils stimulated with C3a and C5a.
Volume: 104 Suppl 1
Issue: 1
Pages: 27-9
Publication
First Author: Schraufstatter IU
Year: 2009
Journal: J Immunol
Title: C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Volume: 182
Issue: 6
Pages: 3827-36
Publication
First Author: Bera MM
Year: 2011
Journal: J Immunol
Title: Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins.
Volume: 187
Issue: 8
Pages: 4245-55
Protein Domain
Type: Family
Description: The activation of the complement cascade produces a number of small fragments that are bioactive: potent chemoattractants and secretagogues that act on immune and non-immune cells []. Similar peptides can also be released by the actions of non-complement proteases, for instance during clotting []. Initially these were termed anaphylatoxins because of their effect on mast cell histamine release, but were reclassified as complement component peptides. They include C3a and C5a, which are involved immune response [], neural development and organ regeneration [, ]. A third peptide, C4a, has a similar structure, but it is inactive in humans []. Since the primary function of complement component peptides is in inflammation, they are important targets for the development of anti-inflammatory therapies [].The anaphylatoxin chemotactic receptors (also known as complement peptide receptors) are a group of rhodopsin-like G-protein coupled receptors (GPCRs) [, , , ]. There are three subtypes: C3a anaphylatoxin chemotactic receptor (C3AR1) [], C5a anaphylatoxin chemotactic receptor (C5AR1) []and C5a anaphylatoxin chemotactic receptor C5L2 (C5AR2) []. Both C3AR1 and C5AR1 receptors are classical GPCRs. However, C5AR2 appears to be permanently uncoupled from G proteins but can associate with beta-arrestin []. Nevertheless, it has been shown that activation of both C5AR1 and C5AR2 is required for a full pro-inflammatory response, particularly in mice []. Several receptor antagonists have been reported [, , , ], although none, so far, have been show to be effective in humans. This entry represents C3AR1, also known as complement component 3a receptor 1 and C3aR []. It appears to be widely expressed in different lymphoid tissues, providing evidence for a central role in inflammatory processes []. This receptor stimulates chemotaxis [], granule enzyme release [, ]and increases phosphorylated-ERK1/2 production []. C3AR1 may provide a theraputic avenue for the treatment of asthma [], retinal degeneration [], and rheumatoid arthritis [].
Publication
First Author: Kalant D
Year: 2005
Journal: J Biol Chem
Title: C5L2 is a functional receptor for acylation-stimulating protein.
Volume: 280
Issue: 25
Pages: 23936-44
Publication
First Author: Ames RS
Year: 1996
Journal: J Biol Chem
Title: Molecular cloning and characterization of the human anaphylatoxin C3a receptor.
Volume: 271
Issue: 34
Pages: 20231-4
Publication
First Author: Monk PN
Year: 2007
Journal: Br J Pharmacol
Title: Function, structure and therapeutic potential of complement C5a receptors.
Volume: 152
Issue: 4
Pages: 429-48
Publication  
First Author: Amara U
Year: 2008
Journal: Adv Exp Med Biol
Title: Interaction between the coagulation and complement system.
Volume: 632
Pages: 71-9
Publication
First Author: Peng Q
Year: 2009
Journal: Inflamm Allergy Drug Targets
Title: The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
Volume: 8
Issue: 3
Pages: 236-46
Publication
First Author: Carmona-Fontaine C
Year: 2011
Journal: Dev Cell
Title: Complement fragment C3a controls mutual cell attraction during collective cell migration.
Volume: 21
Issue: 6
Pages: 1026-37
Publication
First Author: Klos A
Year: 2009
Journal: Mol Immunol
Title: The role of the anaphylatoxins in health and disease.
Volume: 46
Issue: 14
Pages: 2753-66
Publication
First Author: Lienenklaus S
Year: 1998
Journal: J Immunol
Title: Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
Volume: 161
Issue: 5
Pages: 2089-93
Publication  
First Author: Fukuoka Y
Year: 1989
Journal: Dermatologica
Title: Characterization of receptors to the anaphylatoxins on isolated cells.
Volume: 179 Suppl 1
Pages: 35-40
Publication
First Author: Lee DK
Year: 2001
Journal: Brain Res Mol Brain Res
Title: Identification of four novel human G protein-coupled receptors expressed in the brain.
Volume: 86
Issue: 1-2
Pages: 13-22
Publication  
First Author: Gerard C
Year: 1994
Journal: Annu Rev Immunol
Title: C5A anaphylatoxin and its seven transmembrane-segment receptor.
Volume: 12
Pages: 775-808
Publication
First Author: Roglic A
Year: 1996
Journal: Biochim Biophys Acta
Title: cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure.
Volume: 1305
Issue: 1-2
Pages: 39-43
Publication
First Author: Gerard NP
Year: 1991
Journal: Nature
Title: The chemotactic receptor for human C5a anaphylatoxin.
Volume: 349
Issue: 6310
Pages: 614-7
Publication
First Author: Joost P
Year: 2002
Journal: Genome Biol
Title: Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands.
Volume: 3
Issue: 11
Pages: RESEARCH0063
Publication
First Author: Ames RS
Year: 2001
Journal: J Immunol
Title: Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
Volume: 166
Issue: 10
Pages: 6341-8
Publication
First Author: Mathieu MC
Year: 2005
Journal: Immunol Lett
Title: The C3a receptor antagonist SB 290157 has agonist activity.
Volume: 100
Issue: 2
Pages: 139-45
Publication
First Author: Otto M
Year: 2004
Journal: J Biol Chem
Title: C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.
Volume: 279
Issue: 1
Pages: 142-51
Publication  
First Author: Perrino MR
Year: 2024
Journal: Life Sci Alliance
Title: C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.
Volume: 7
Issue: 5
Publication
First Author: Farini A
Year: 2022
Journal: Cell Death Dis
Title: Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice.
Volume: 13
Issue: 11
Pages: 975
Publication
First Author: Biggins PJC
Year: 2017
Journal: J Neurotrauma
Title: The Alternative Receptor for Complement Component 5a, C5aR2, Conveys Neuroprotection in Traumatic Spinal Cord Injury.
Volume: 34
Issue: 12
Pages: 2075-2085
Publication
First Author: Desai JV
Year: 2023
Journal: Cell
Title: C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection.
Volume: 186
Issue: 13
Pages: 2802-2822.e22
Publication
First Author: Kaur G
Year: 2023
Journal: PLoS One
Title: Helicase-like transcription factor (Hltf)-deletion activates Hmgb1-Rage axis and granzyme A-mediated killing of pancreatic β cells resulting in neonatal lethality.
Volume: 18
Issue: 8
Pages: e0286109
Publication  
First Author: Coulthard LG
Year: 2018
Journal: Mol Immunol
Title: Complement C3a receptor modulates embryonic neural progenitor cell proliferation and cognitive performance.
Volume: 101
Pages: 176-181
Publication  
First Author: Manouchehri N
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity.
Volume: 118
Issue: 14
Publication
First Author: Karsten CM
Year: 2017
Journal: J Immunol
Title: Monitoring C5aR2 Expression Using a Floxed tdTomato-C5aR2 Knock-In Mouse.
Volume: 199
Issue: 9
Pages: 3234-3248
Publication
First Author: Denk S
Year: 2017
Journal: J Immunol
Title: Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
Volume: 198
Issue: 12
Pages: 4846-4854
Publication
First Author: Wu MCL
Year: 2020
Journal: J Immunol
Title: Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
Volume: 205
Issue: 10
Pages: 2834-2839
Publication  
First Author: Shende R
Year: 2022
Journal: Front Immunol
Title: Protective role of host complement system in Aspergillus fumigatus infection.
Volume: 13
Pages: 978152
Publication
First Author: Crass T
Year: 1996
Journal: Eur J Immunol
Title: Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells.
Volume: 26
Issue: 8
Pages: 1944-50
Protein
Organism: Mus musculus/domesticus
Length: 344  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 477  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 477  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 358  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 477  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 226  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 358  
Fragment?: false
Publication
First Author: Mahajan SD
Year: 2016
Journal: Immunology
Title: C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus.
Volume: 148
Issue: 4
Pages: 407-19
Publication  
First Author: Seiler DL
Year: 2023
Journal: Front Immunol
Title: The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.
Volume: 14
Pages: 1197709
Publication
First Author: Wiese AV
Year: 2017
Journal: PLoS One
Title: The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells.
Volume: 12
Issue: 9
Pages: e0184956
Publication  
First Author: Merle NS
Year: 2020
Journal: Front Immunol
Title: Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.
Volume: 11
Pages: 1772
Protein
Organism: Mus musculus/domesticus
Length: 351  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 301  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 181  
Fragment?: true